Synergistic effects of sonoporation and taurolidin/TRAIL on apoptosis in human fibrosarcoma

Ultrasound in Medicine and Biology

Volumn 36, Issue 11, 2010, Pages 1893-1906

  Daigeler, Adrien ^a   Chromik, Ansgar M ^b   Haendschke, Kathrin ^c   Emmelmann, Sabine ^c   Siepmann, Monica ^d   Hensel, Karin ^d   Schmitz, Georg ^d   Klein Hitpass, Ludger ^e   Steinau, Hans U ^c   Lehnhardt, Marcus ^a   Hauser, Joerg ^c  

^a Burn Centre   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Apoptosis; Fibrosarcoma; Soft tissue sarcoma; Sonication; Sonodynamic therapy; Sonoporation; Taurolidine; TRAIL; Ultrasound

Indexed keywords

APOPTOSIS; FIBROSARCOMA; SOFT TISSUE SARCOMA; SONODYNAMIC THERAPY; SONOPORATION; TAUROLIDINE; TRAIL; ULTRASOUND;

GENE EXPRESSION; RNA; SONICATION; TUMORS; ULTRASONICS;

CELL DEATH;

CONTRAST MEDIUM; RECOMBINANT PROTEIN; SONOVUE; TAUROLIDINE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; FIBROSARCOMA; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROARRAY ANALYSIS; MICROBUBBLE; NICK END LABELING; PRIORITY JOURNAL; RNA ANALYSIS; UPREGULATION;

ANALYSIS OF VARIANCE; APOPTOSIS; CONTRAST MEDIA; FIBROSARCOMA; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IN SITU NICK-END LABELING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOLIPIDS; SOFT TISSUE NEOPLASMS; SULFUR HEXAFLUORIDE; TAURINE; THIADIAZINES; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; ULTRASONIC THERAPY;

EID: 77958152696     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2010.08.009     Document Type: Article

References (79)

1. Abdollahi A., Domhan S., Jenne J.W., Hallaj M., Dell'Aqua G., Mueckenthaler M., Richter A., Martin H., Debus J., Ansorge W., Hynynen K., Huber P.E. Apoptosis signals in lymphoblasts induced by focused ultrasound. FASEB J 2004, 18:1413-1414.
2. Alter J., Sennoga C.A., Lopes D.M., Eckersley R.J., Wells D.J. Microbubble stability is a major determinant of the efficiency of ultrasound and microbubble mediated in vivo gene transfer. Ultrasound Med Biol 2009, 35:976-984.
3. Ankarcrona M., Dypbukt J.M., Orrenius S., Nicotera P. Calcineurin and mitochondrial function in glutamate-induced neuronal cell death. FEBS Lett 1996, 394:321-324.
4. Asada A., Zhao Y., Kondo S., Iwata M. Induction of thymocyte apoptosis by Ca2+-independent protein kinase C (nPKC) activation and its regulation by calcineurin activation. J Biol Chem 1998, 273:28392-28398.
5. Baines C.P., Molkentin J.D. STRESS signaling pathways that modulate cardiac myocyte apoptosis. J Mol Cell Cardiol 2005, 38:47-62.
6. Braumann C., Henke W., Jacobi C.A., Dubiel W. The tumor-suppressive reagent taurolidine is an inhibitor of protein biosynthesis. Int J Cancer 2004, 112:225-230.
7. Braumann C., Winkler G., Rogalla P., Menenakos C., Jacobi C.A. Prevention of disease progression in a patient with a gastric cancer-re-recurrence. Outcome after intravenous treatment with the novel antineoplastic agent taurolidine. World J Surg Oncol 2006, 4:34. Report of a case.
8. Brickell P.M. The p60c-src family of protein-tyrosine kinases: Structure, regulation, and function. Crit Rev Oncog 1992, 3:401-446.
9. Calabresi P., Goulette F.A., Darnowski J.W. Taurolidine: Cytotoxic and mechanistic evaluation of a novel antineoplastic agent. Cancer Res 2001, 61:6816-6821.
10. Cattaneo E., Zuccato C., Tartari M. Normal huntingtin function: An alternative approach to Huntington's disease. Nat Rev Neurosci 2005, 6:919-930.
11. Cherix S., Speiser M., Matter M., Raffoul W., Lienard D., Theumann N., Mouhsine E., Mirimanoff R.O., Leyvraz S., Lejeune F.J., Leyvraz P.F. Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: Long-term results on efficacy and limb salvage in a selected group of patients. J Surg Oncol 2008, 98:148-155.
12. Chromik A.M., Daigeler A., Bulut D., Flier A., May C., Harati K., Roschinsky J., Sulberg D., Ritter P.R., Mittelkotter U., Hahn S.A., Uhl W. Comparative analysis of cell death induction by Taurolidine in different malignant human cancer cell lines. J Exp Clin Cancer Res 2010, 29:21.
13. Chromik A.M., Daigeler A., Hilgert C., Bulut D., Geisler A., Liu V., Otte J.M., Uhl W., Mittelkotter U. Synergistic effects in apoptosis induction by taurolidine and TRAIL in HCT-15 colon carcinoma cells. J Invest Surg 2007, 20:339-348.
14. Cooper J.T., Stroka D.M., Brostjan C., Palmetshofer A., Bach F.H., Ferran C. A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism. J Biol Chem 1996, 271:18068-18073.
15. Daigeler A., Brenzel C., Bulut D., Geisler A., Hilgert C., Lehnhardt M., Steinau H.U., Flier A., Steinstraesser L., Klein-Hitpass L., Mittelkotter U., Uhl W., Chromik A.M. TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma. J Exp Clin Cancer Res 2008, 27:82.
16. Daigeler A., Chromik A.M., Geisler A., Bulut D., Hilgert C., Krieg A., Klein-Hitpass L., Lehnhardt M., Uhl W., Mittelkotter U. Synergistic apoptotic effects of taurolidine and TRAIL on squamous carcinoma cells of the esophagus. Int J Oncol 2008, 32:1205-1220.
17. Daigeler A., Klein-Hitpass L., Chromik M.A., Muller O., Hauser J., Homann H.H., Steinau H.U., Lehnhardt M. Heterogeneous in vitro effects of doxorubicin on gene expression in primary human liposarcoma cultures. BMC Cancer 2008, 8:313.
18. Daigeler A., Lehnhardt M., Khadra A., Hauser J., Steinstraesser L., Langer S., Goertz O., Steinau H.U. Proximal major limb amputations-A retrospective analysis of 45 oncological cases. World J Surg Oncol 2009, 7:15.
19. Davidovich I.A., Levenson A.S., Levenson Chernokhvostov V.V. Overexpression of DcR1 and survivin in genetically modified cells with pleiotropic drug resistance. Cancer Lett 2004, 211:189-197.
20. Dey B.R., Spence S.L., Nissley P., Furlanetto R.W. Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor. J Biol Chem 1998, 273:24095-24101.
21. Donato Di Paola E., Nielsen O.S. The EORTC soft tissue and bone sarcoma group. Eur J Cancer 2002, 38(Suppl 4):138-141.
22. Feril L.B., Kondo T., Zhao Q.L., Ogawa R., Tachibana K., Kudo N., Fujimoto S., Nakamura S. Enhancement of ultrasound-induced apoptosis and cell lysis by echo-contrast agents. Ultrasound Med Biol 2003, 29:331-337.
23. Firestein F., Rozenszajn L.A., Shemesh-Darvish L., Elimelech R., Radnay J., Rosenschein U. Induction of apoptosis by ultrasound application in human malignant lymphoid cells: role of mitochondria-caspase pathway activation. Ann N Y Acad Sci 2003, 1010:163-166.
24. Gehrmann M. Drug evaluation: STA-4783-enhancing taxane efficacy by induction of Hsp70. Curr Opin Investig Drugs 2006, 7:574-580.
25. Greenhalgh C.J., Bertolino P., Asa S.L., Metcalf D., Corbin J.E., Adams T.E., Davey H.W., Nicola N.A., Hilton D.J., Alexander W.S. Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b). Mol Endocrinol 2002, 16:1394-1406.
26. Grunhagen D.J., de Wilt J.H., Graveland W.J., Verhoef C., van Geel A.N., Eggermont A.M. Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma. Cancer 2006, 106:1776-1784.
27. Haga A., Funasaka T., Niinaka Y., Raz A., Nagase H. Autocrine motility factor signaling induces tumor apoptotic resistance by regulations Apaf-1 and Caspase-9 apoptosome expression. Int J Cancer 2003, 107:707-714.
28. Harrison G.H., Balcer-Kubiczek E.K., Eddy H.A. Potentiation of chemotherapy by low-level ultrasound. Int J Radiat Biol 1991, 59:1453-1466.
29. Hauptschein R.S., Sloan K.E., Torella C., Moezzifard R., Giel-Moloney M., Zehetmeier C., Unger C., Ilag L.L., Jay D.G. Functional proteomic screen identifies a modulating role for CD44 in death receptor-mediated apoptosis. Cancer Res 2005, 65:1887-1896.
30. Hensel K.S.M., Haendschke K., Emmelmann S., Daigeler A., Hauser J., Schmitz G. Monitoring of insonicated microbubble behavior and their effect on sonoporation supported chemotherapy of fibrosarcoma cells. IFMBE Proc 2009, 22:1422-1425.
31. Heyninck K., Denecker G., De Valck D., Fiers W., Beyaert R. Inhibition of tumor necrosis factor-induced necrotic cell death by the zinc finger protein A20. Anticancer Res 1999, 19:2863-2868.
32. Honda H., Zhao Q.L., Kondo T. Effects of dissolved gases and an echo contrast agent on apoptosis induced by ultrasound and its mechanism via the mitochondria-caspase pathway. Ultrasound Med Biol 2002, 28:673-682.
33. Hu Q., Zhou M.X., Liu S.Y., Zhang L.Q., Liu A.Q., Guo Y.J., Song Y. [Regulation of NF-kappaB/P65 by MDM2 in acute lymphoblastic leukemia in childhood]. Zhonghua Er Ke Za Zhi 2003, 41:921-924.
34. Jayaraman T., Marks A.R. Calcineurin is downstream of the inositol 1,4,5-trisphosphate receptor in the apoptotic and cell growth pathways. J Biol Chem 2000, 275:6417-6420.
35. Juffermans L.J., Meijering D.B., van Wamel A., Henning R.H., Kooiman K., Emmer M., de Jong N., van Gilst W.H., Musters R., Paulus W.J., van Rossum A.C., Deelman L.E., Kamp O. Ultrasound and microbubble-targeted delivery of therapeutic compounds: ICIN Report Project 49: Drug and gene delivery through ultrasound and microbubbles. Neth Heart J 2009, 17:82-86.
36. Juffermans L.J., van Dijk A., Jongenelen C.A., Drukarch B., Reijerkerk A., de Vries H.E., Kamp O., Musters R.J. Ultrasound and microbubble-induced intra- and intercellular bioeffects in primary endothelial cells. Ultrasound Med Biol 2009, 35:1917-1927.
37. Kappler M., Kohler T., Kampf C., Diestelkotter P., Wurl P., Schmitz M., Bartel F., Lautenschlager C., Rieber E.P., Schmidt H., Bache M., Taubert H., Meye A. Increased survivin transcript levels: An independent negative predictor of survival in soft tissue sarcoma patients. Int J Cancer 2001, 95:360-363.
38. Kappler M., Kotzsch M., Bartel F., Fussel S., Lautenschlager C., Schmidt U., Wurl P., Bache M., Schmidt H., Taubert H., Meye A. Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival. Clin Cancer Res 2003, 9:1098-1104.
39. Karshafian R., Bevan P.D., Williams R., Samac S., Burns P.N. Sonoporation by ultrasound-activated microbubble contrast agents: Effect of acoustic exposure parameters on cell membrane permeability and cell viability. Ultrasound Med Biol 2009, 35:847-860.
40. Khanna S., Hudson B., Pepper C.J., Amso N.N., Coakley W.T. Fluorescein isothiocynate-dextran uptake by chinese hamster ovary cells in a 1.5 MHz ultrasonic standing wave in the presence of contrast agent. Ultrasound Med Biol 2006, 32:289-295.
41. Kilic M., Kasperczyk H., Fulda S., Debatin K.M. Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance. Oncogene 2007, 26:2027-2038.
42. Kodama T., Doukas A.G., Hamblin M.R. Shock wave-mediated molecular delivery into cells. Biochim Biophys Acta 2002, 1542:186-194.
43. Kogerman P., Sy M.S., Culp L.A. Overexpressed human CD44s promotes lung colonization during micrometastasis of murine fibrosarcoma cells: Facilitated retention in the lung vasculature. Proc Natl Acad Sci U S A 1997, 94:13233-13238.
44. Lentacker I., Geers B., Demeester J., De Smedt S.C., Sanders N.N. Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: Cytotoxicity and mechanisms involved. Mol Ther 2010, 18:101-108.
45. Li H.L., Zhuo M.L., Wang D., Wang A.B., Cai H., Sun L.H., Yang Q., Huang Y., Wei Y.S., Liu P.P., Liu D.P., Liang C.C. Targeted cardiac overexpression of A20 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circulation 2007, 115:1885-1894.
46. Loverock P., ter Haar G., Ormerod M.G., Imrie P.R. The effect of ultrasound on the cytotoxicity of adriamycin. Br J Radiol 1990, 63:542-546.
47. Mayadas T.N., Cullere X. Neutrophil beta2 integrins: Moderators of life or death decisions. Trends Immunol 2005, 26:388-395.
48. McCourt M., Wang J.H., Sookhai S., Redmond H.P. Taurolidine inhibits tumor cell growth in vitro and in vivo. Ann Surg Oncol 2000, 7:685-691.
49. Miller D.L., Quddus J. Sonoporation of monolayer cells by diagnostic ultrasound activation of contrast-agent gas bodies. Ultrasound Med Biol 2000, 26:661-667.
50. Mizuno Y., Iwata H., Takagi H., Yoshikawa S., Umeda Y., Matsuno Y., Mori Y., Takemura H. Sonoporation with doxorubicin enhances suppression of intimal hyperplasia in a vein graft model. J Surg Res 2005, 124:312-317.
51. Mohamed M.M., Mohamed M.A., Fikry N.M. Enhancement of antitumor effects of 5-fluorouracil combined with ultrasound on Ehrlich ascites tumor in vivo. Ultrasound Med Biol 2003, 29:1635-1643.
52. Nakatsu N., Yoshida Y., Yamazaki K., Nakamura T., Dan S., Fukui Y., Yamori T. Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays. Mol Cancer Ther 2005, 4:399-412.
53. Nomura T., Yamasaki M., Nomura Y., Mimata H. Expression of the inhibitors of apoptosis proteins in cisplatin-resistant prostate cancer cells. Oncol Rep 2005, 14:993-997.
54. Park J.M., Kim A., Oh J.H., Chung A.S. Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-κB activation. Carcinogenesis 2007, 28:837-847.
55. Reichardt H.M. Immunomodulatory activities of glucocorticoids: Insights from transgenesis and gene targeting. Curr Pharm Des 2004, 10:2797-2805.
56. Rosenthal I., Sostaric J.Z., Riesz P. Sonodynamic therapy-A review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem 2004, 11:349-363.
57. Saad A.H., Hahn G.M. Ultrasound-enhanced effects of adriamycin against murine tumors. Ultrasound Med Biol 1992, 18:715-723.
58. Schlicher R.K., Radhakrishna H., Tolentino T.P., Apkarian R.P., Zarnitsyn V., Prausnitz M.R. Mechanism of intracellular delivery by acoustic cavitation. Ultrasound Med Biol 2006, 32:915-924.
59. Schneider M., Arditi M., Barrau M.B., Brochot J., Broillet A., Ventrone R., Yan F. BR1: A new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles. Invest Radiol 1995, 30:451-457.
60. Shibasaki F., McKeon F. Calcineurin functions in Ca(2+)-activated cell death in mammalian cells. J Cell Biol 1995, 131:735-743.
61. Singer S., Corson J.M., Demetri G.D., Healey E.A., Marcus K., Eberlein T.J. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg 1995, 221:185-195.
62. Sorensen S.A., Fenger K., Olsen J.H. Significantly lower incidence of cancer among patients with Huntington disease: An apoptotic effect of an expanded polyglutamine tract?. Cancer 1999, 86:1342-1346.
63. Steinau H.U., Buttemeyer R., Vogt P., Hussmann J., Hebebrand D. Limb salvage and reconstructive procedures in soft tissue sarcomas of the extremities. Recent Results Cancer Res 1995, 138:31-39.
64. Stendel R., Scheurer L., Schlatterer K., Stalder U., Pfirrmann R.W., Fiss I., Mohler H., Bigler L. Pharmacokinetics of taurolidine following repeated intravenous infusions measured by HPLC-ESI-MS/MS of the derivatives taurultame and taurinamide in glioblastoma patients. Clin Pharmacokinet 2007, 46:513-524.
65. Sur P., Ghosh P., Bag S.P., Sur B., Chatterjee S.N. On the inhibitory activities of a new boron compound and ultrasound against the mouse ascites tumour. Chemotherapy 1999, 45:360-369.
66. Tabuchi Y., Ando H., Takasaki I., Feril L.B., Zhao Q.L., Ogawa R., Kudo N., Tachibana K., Kondo T. Identification of genes responsive to low intensity pulsed ultrasound in a human leukemia cell line Molt-4. Cancer Lett 2007, 246:149-156.
67. Tachibana K., Uchida T., Ogawa K., Yamashita N., Tamura K. Induction of cell-membrane porosity by ultrasound. Lancet 1999, 353:1409.
68. Takayama T., Mogi Y., Kogawa K., Yoshizaki N., Muramatsu H., Koike K., Semba K., Yamamoto T., Niitsu Y. A role for the fyn oncogene in metastasis of methylcholanthrene-induced fibrosarcoma A cells. Int J Cancer 1993, 54:875-879.
69. Tang W., Liu Q., Wang X., Wang P., Zhang J., Cao B. Potential mechanism in sonodynamic therapy and focused ultrasound induced apoptosis in sarcoma 180 cells in vitro. Ultrasonics 2009, 49:786-793.
70. Tang W., Liu Q., Zhang J., Cao B., Zhoa P., Qin X. In vitro activation of mitochondria-caspase signaling pathway in sonodynamic therapy-induced apoptosis in sarcoma 180 cells. Ultrasonics 2010, (in press).
71. Tombal B., Weeraratna A.T., Denmeade S.R., Isaacs J.T. Thapsigargin induces a calmodulin/calcineurin-dependent apoptotic cascade responsible for the death of prostatic cancer cells. Prostate 2000, 43:303-317.
72. Varfolomeev E., Vucic D. (Un)expected roles of c-IAPs in apoptotic and NFkappaB signaling pathways. Cell Cycle 2008, 7.
73. Ward M., Wu J., Chiu J.F. Ultrasound-induced cell lysis and sonoporation enhanced by contrast agents. J Acoust Soc Am 1999, 105:2951-2957.
74. Wikman H., Kettunen E., Seppanen J.K., Karjalainen A., Hollmen J., Anttila S., Knuutila S. Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene 2002, 21:5804-5813.
75. Wu F., Wang Z.B., Cao Y.D., Chen W.Z., Zou J.Z., Bai J., Zhu H., Li K.Q., Jin C.B., Xie F.L., Su H.B., Gao G.W. Changes in biologic characteristics of breast cancer treated with high-intensity focused ultrasound. Ultrasound Med Biol 2003, 29:1487-1492.
76. Wu J., Nyborg W.L. Ultrasound, cavitation bubbles and their interaction with cells. Adv Drug Deliv Rev 2008, 60:1103-1116.
77. Wu J., Ross J.P., Chiu J.F. Reparable sonoporation generated by microstreaming. J Acoust Soc Am 2002, 111:1460-1464.
78. Yu T., Wang Z., Jiang S. Potentiation of cytotoxicity of adriamycin on human ovarian carcinoma cell line 3AO by low-level ultrasound. Ultrasonics 2001, 39:307-309.
79. Yumita N., Kawabata K., Sasaki K., Umemura S. Sonodynamic effect of erythrosin B on sarcoma 180 cells in vitro. Ultrason Sonochem 2002, 9:259-265.